Market Research Logo

North America and Europe Peptide Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

North America and Europe Peptide Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

Scope of the Report:
This report focuses on the Peptide Therapeutics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain

Market Segment by Type, covers
Injection
Oral
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

There are 19 Chapters to deeply display the North America and Europe Peptide Therapeutics market.

Chapter 1, to describe Peptide Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Peptide Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Peptide Therapeutics, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;

Chapter 14, Peptide Therapeutics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.


1 Market Overview
1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Oral
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Metabolic Disorders
1.3.3 Central Nervous System
1.3.4 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Peptide Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Peptide Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk
2.3.1 Business Overview
2.3.2 Peptide Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Peptide Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Peptide Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Peptide Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Peptide Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shire
2.8.1 Business Overview
2.8.2 Peptide Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Peptide Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ipsen
2.10.1 Business Overview
2.10.2 Peptide Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Allergan
2.11.1 Business Overview
2.11.2 Peptide Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring
2.12.1 Business Overview
2.12.2 Peptide Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Peptide Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 The Medicines
2.14.1 Business Overview
2.14.2 Peptide Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Peptide Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 J & J
2.16.1 Business Overview
2.16.2 Peptide Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Peptide Therapeutics Market Competition, by Manufacturer
3.1 North America and Europe Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Peptide Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Peptide Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Peptide Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Peptide Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Peptide Therapeutics Market Analysis by Countries/Regions
4.1 North America and Europe Peptide Therapeutics Sales Market Share by Countries/Regions
4.2 North America and Europe Peptide Therapeutics Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Peptide Therapeutics Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Peptide Therapeutics Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Peptide Therapeutics Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Peptide Therapeutics by Type
5.1 North America and Europe Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Peptide Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
5.2 Injection Sales Growth and Price
5.2.1 North America and Europe Injection Sales Growth (2013-2018)
5.2.2 North America and Europe Injection Price (2013-2018)
5.3 Oral Sales Growth and Price
5.3.1 North America and Europe Oral Sales Growth (2013-2018)
5.3.2 North America and Europe Oral Price (2013-2018)
5.4 Other Sales Growth and Price
5.4.1 North America and Europe Other Sales Growth (2013-2018)
6 North America and Europe Market Segmentation Peptide Therapeutics by Application
6.1 North America and Europe Peptide Therapeutics Sales Market Share by Application (2013-2018)
6.2 Cancer Sales Growth (2013-2018)
6.3 Metabolic Disorders Sales Growth (2013-2018)
6.4 Central Nervous System Sales Growth (2013-2018)
6.5 Other Sales Growth (2013-2018)
7 United States Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Peptide Therapeutics Sales and Market Share by Type (2013-2018)
7.2.1 United States Peptide Therapeutics Sales by Type (2013-2018)
7.2.2 United States Peptide Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Peptide Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Peptide Therapeutics Sales by Application (2013-2018)
7.3.2 United States Peptide Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Peptide Therapeutics Export and Import (2013-2018)
8 United Kingdom Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Peptide Therapeutics Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Peptide Therapeutics Sales by Type (2013-2018)
8.2.2 United Kingdom Peptide Therapeutics Sales Market Share by Type (2013-2018)
8.3 United Kingdom Peptide Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Peptide Therapeutics Sales by Application (2013-2018)
8.3.2 United Kingdom Peptide Therapeutics Sales Market Share by Application (2013-2018)
8.4 United Kingdom Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Peptide Therapeutics Export and Import (2013-2018)
9 Canada Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Peptide Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Canada Peptide Therapeutics Sales by Type (2013-2018)
9.2.2 Canada Peptide Therapeutics Sales Market Share by Type (2013-2018)
9.3 Canada Sales and Market Share by Application (2013-2018)"
"
9.3.1 Canada Peptide Therapeutics Sales by Application (2013-2018)
9.3.2 Canada Peptide Therapeutics Sales Market Share by Application (2013-2018)
9.4 Canada Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Peptide Therapeutics Export and Import (2013-2018)
10 Germany Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Peptide Therapeutics Sales and Market Share by Type (2013-2018)
10.2.1 Germany Peptide Therapeutics Sales by Type (2013-2018)
10.2.2 Germany Peptide Therapeutics Sales Market Share by Type (2013-2018)
10.3 Germany Peptide Therapeutics Sales and Market Share by Application (2013-2018)
10.3.1 Germany Peptide Therapeutics Sales by Application (2013-2018)
10.3.2 Germany Peptide Therapeutics Sales Market Share by Application (2013-2018)
10.4 Germany Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Peptide Therapeutics Export and Import (2013-2018)
11 France Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
11.1 France Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
11.2 France Peptide Therapeutics Sales and Market Share by Type (2013-2018)
11.2.1 France Peptide Therapeutics Sales by Type (2013-2018)
11.2.2 France Peptide Therapeutics Sales Market Share by Type (2013-2018)
11.3 France Sales by Application (2013-2018)"
"
11.3.1 France Peptide Therapeutics Sales by Application (2013-2018)
11.3.2 France Peptide Therapeutics Sales Market Share by Application (2013-2018)
11.4 France Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Peptide Therapeutics Revenue and Market Share by Manufacturer
11.5 France Peptide Therapeutics Export and Import (2013-2018)
12 Italy Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Peptide Therapeutics Sales and Market Share by Type (2013-2018)
12.2.1 Italy Peptide Therapeutics Sales by Type (2013-2018)
12.2.2 Italy Peptide Therapeutics Sales Market Share by Type (2013-2018)
12.3 Italy Peptide Therapeutics Sales and Market Share by Application (2013-2018)
12.3.1 Italy Peptide Therapeutics Sales by Application (2013-2018)
12.3.2 Italy Peptide Therapeutics Sales Market Share by Application (2013-2018)
12.4 Italy Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Peptide Therapeutics Export and Import (2013-2018)
13 Spain Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Peptide Therapeutics Sales and Market Share by Type (2013-2018)
13.2.1 Spain Peptide Therapeutics Sales by Type (2013-2018)
13.2.2 Spain Peptide Therapeutics Sales Market Share by Type (2013-2018)
13.3 Spain Peptide Therapeutics Sales by Application (2013-2018)
13.3.1 Spain Peptide Therapeutics Sales by Application (2013-2018)
13.3.2 Spain Peptide Therapeutics Sales Market Share by Application (2013-2018)
13.4 Spain Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Peptide Therapeutics Export and Import (2013-2018)
14 Peptide Therapeutics Market Forecast (2018-2023)
14.1 North America and Europe Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
14.2 Peptide Therapeutics Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Peptide Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.3 Peptide Therapeutics Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Peptide Therapeutics Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Peptide Therapeutics Market Share Forecast by Type (2018-2023)
14.4 Peptide Therapeutics Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Peptide Therapeutics Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Peptide Therapeutics Market Share Forecast by Application (2018-2023)
15 Peptide Therapeutics Manufacturing Cost Analysis
15.1 Peptide Therapeutics Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Peptide Therapeutics
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Peptide Therapeutics Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report